Autoantibodies to chromatin: Prevalence and clinical significance in juvenile rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 22, Issue 4, 2004, Pages 499-501

  Ingegnoli, Francesca ^a   Del Papa, Nicolletta ^a   Comina, Denise Provvidenza ^a   Maglione, Wanda ^a   Lupi, Elide ^a   Gerloni, Valeria ^a   Fantini, Flavio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Anti chromatin antibody; Juvenile rheumatoid arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; CHROMATIN ANTIBODY; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; STATISTICAL ANALYSIS; UVEITIS;

ANTIBODIES, ANTINUCLEAR; ARTHRITIS, JUVENILE RHEUMATOID; CHROMATIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE;

EID: 4143088175     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. LAWRENCE III JM, MOORE TL, OSBORN TG, NESHER G, MADISON KL, KINSELLA MB: Autoantibody studies in juvenile rheumatoid arthritis. Semin Arthritis Rheum 1993; 22: 265-74.
2. SERRA CRB, RODRIGUES SH, SILVA NP, SZTAJNBOK FR, ANDRADE LEC: Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis. Clin Exp Rheumural 1999; 17: 375-80.
3. NESHER G, MOORE TL, GRISANTI MW, ELNAJDAWI E, OSBORN TG: Antiperinuclear factor in juvenile rheumatoid arthritis. Ann Rheum Dis 1992; 51: 350-2.
4. GABAY C, PRIEUR AM, MEYER O: Occurrence of antiperinuclear, antikeratin, and anti-RA33 antibodies in juvenile rheumatoid arthritis. Ann Rheum Dis 1993; 52: 785-789.
5. AVCIN T, CIMAZ R, FALCINI F et al.: Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2002; 61: 608-11.
6. ROSENBERG AM: Clinical association of antinuclear antibodies in juvenile rheumatoid arthritis. Clin Immunol Immunopathol 1988; 49: 19-27.
7. MALLESON P, PETTY RE, FUNG M, CANDIDO PM: Reactivity of antinuclear antibodies with histones and other antigens in juvenile rheumatoid arthritis. Arthritis Rheum 1989; 32: 919-23.
8. MONESTIER M, LOSMAN JA, FASY TM et al.: Antihistone antibodies in antinuclear antibody-positive juvenile arthritis. Arthritis Rheum 1990; 33: 1836-41.
9. PAULS JD, SILVERMAN E, LAXER RM, FRITZLER MJ: Antibodies to histories H1 and H5 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 1989; 32: 877-83.
10. BURLINGAME RW, RUBIN RL, ROSENBERG AM: Autoantibodies to chromatin components in juvenile rheumatoid arthritis. Arthritis Rheum 1993; 36: 836-41.
11. LEAK AM, TUAILLON N, MULLER S, WOO P: Study of antibodies to histories and histone synthetic peptides in pauciarticular juvenile chronic arthritis. Br J Rheumatol 1993; 32: 426-31.
12. BREWER EJ JR, BASS J et al.: Current proposed revision of JRA criteria. Arthritis Rheum 1977; 20 (Suppl. 2): 195-9.
13. TUAILON N, MULLER S, PASQUALI JL, BORDIGON P, VAN REGENMORTEL MHV: Antibodies from patients with rheumatoid arthritis and juvenile chronic arthritis analyzed with core histone synthetic peptides. Arch Allergy Appl Immunol 1990; 91: 297.
14. MASSA M, DE BENEDETTI F, PIGNATTI P et al.: Lack of temporal association of iridocyclitis with IgG reactivities to core histones and nucleosome subparticles in pauciarticular juvenile chronic arthritis. Br J Rhumatol 1995; 34: 507.
15. GUILLAUME S, PRIEUR A, COSTE J et al.: Long-term outcome and prognosis in oligoarticular - onset juvenile rheumatoid arthritis. Arthritis Rheum 2000; 43: 1858-65.